MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-31, XNCR made $4.516M in revenue. -$128.916M in net income. Net profit margin of -2854.65%.

Income Overview

Revenue
$4.516M
Net Income
-$128.916M
Net Profit Margin
-2854.65%
EPS
-$1.71
Unit: Million (M) dollars
Revenue Breakdown
    • Incyte Corporation
    • Alexion Pharmaceuticals Inc
Revenue Breakdown
    • Incyte Corporation
    • Alexion Pharmaceuticals Inc
    • Other
Revenue Breakdown
    • Royalty
    • License

Income Statement
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Collaborations, milestones, and royalties
4.516 28.237 20.999 43.608
Research and development
64.669 64.824 54.367 61.665
General and administrative
17.709 17.041 14.151 15.115
Total operating expenses
82.378 81.865 68.518 76.78
Operating loss
-77.862 -53.628 -47.519 -33.172
Interest income
5.459 6.2 6.538 7.248
Interest expense
4.7 7.354 7.665 8.243
(losses) gains on equity securities, net
-51.929 51.405 44.201 4.967
Asset impairment charges
0 0.881 1.565 1.858
Other, net
0.396 -0.008 -0.017 -0.017
Total other expense
-50.774 49.362 41.492 2.097
Loss before income tax expense and noncontrolling interest
-128.636 -4.266 -6.027 -31.075
Income tax expense
0.28 2.387 0 -0.25
Net loss including noncontrolling interest
-128.916 -6.653 -6.027 -30.825
Net loss attributable to noncontrolling interest
0 0 0 0
Net loss attributable to xencor, inc
-128.916 -6.653 -6.027 -30.825
Basic EPS
-1.71 -0.089 -0.08 -0.41
Diluted EPS
-1.71 -0.089 -0.08 -0.41
Basic Average Shares
75,247,000 74,597,000 74,413,000 74,279,000
Diluted Average Shares
75,247,000 74,597,000 74,413,000 74,279,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Net lossattributable to xencor, inc-$128.916M (-166.26%↓ Y/Y)Net loss includingnoncontrolling interest-$128.916M (-165.08%↓ Y/Y)Loss before incometax expense and...-$128.636M (-166.52%↓ Y/Y)Income tax expense$0.28M (-23.71%↓ Y/Y)Incyte Corporation$2.936M AlexionPharmaceuticals Inc$1.48M (-90.43%↓ Y/Y)Operating loss-$77.862M (-80.31%↓ Y/Y)Total other expense-$50.774M (-899.09%↓ Y/Y)Collaborations, milestones, androyalties$4.516M (-86.20%↓ Y/Y)Interest income$5.459M (-27.58%↓ Y/Y)Other, net$0.396M (1377.42%↑ Y/Y)Total operatingexpenses$82.378M (8.51%↑ Y/Y)(losses) gains on equitysecurities, net-$51.929M (-5618.49%↓ Y/Y)Interest expense$4.7M (-45.76%↓ Y/Y)Research and development$64.669M (10.40%↑ Y/Y)General andadministrative$17.709M (2.15%↑ Y/Y)

Xencor Inc (XNCR)

Xencor Inc (XNCR)